Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR/A | 0001065350-22-000011 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital World Investors | 1422849 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 69546 | 2274974 | SH | DFND | 1, 2 | 2274974 | 0 | 0 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR/A | 0001065350-22-000006 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital International Investors | 1562230 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 26544 | 868297 | SH | DFND | 1, 2 | 868297 | 0 | 0 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Xenon Pharmaceuticals Inc | Equity | 98420N105 | 40780 | 1334 | SH | DFND | 1 | 0 | 1334 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 633 | 20700 | SH | Put | DFND | 2 | 20700 | 0 | 0 | May 18th, 2022 01:14AM | May 18th, 2022 01:14AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 162 | 5286 | SH | DFND | 2 | 5286 | 0 | 0 | May 18th, 2022 01:14AM | May 18th, 2022 01:14AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 331 | 10831 | SH | DFND | 1 | 10831 | 0 | 0 | May 18th, 2022 01:14AM | May 18th, 2022 01:14AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001387131-22-006230 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Advisors Asset Management, Inc. | 1297376 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 66 | 2148 | SH | SOLE | 2148 | 0 | 0 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001831942-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | COMMODORE CAPITAL LP | 1831942 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 36764 | 1202613 | SH | SOLE | 1202613 | 0 | 0 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001803916-22-000005 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Aquatic Capital Management LLC | 1803916 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 12 | 400 | SH | SOLE | 0 | 0 | 400 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:xene | nasdaq:xene Shareholders | 13F-HR | 0001802630-22-000005 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Soleus Capital Management, L.P. | 1802630 | XENON PHARMACEUTICALS INC | COM | 98420N105 | 5802 | 189797 | SH | SOLE | 189797 | 0 | 0 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | Xenon Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |